Enochian Biosciences CEO Mark Dybul's 2022 pay jumps 2,400% to $11M
Enochian Biosciences reports 2022 executive compensation
By ExecPay News
Published: May 16, 2023
Enochian Biosciences reported fiscal year 2022 executive compensation information on May 16, 2023.
In 2022, two executives at Enochian Biosciences received on average a compensation package of $5.8M, a 1,537% increase compared to previous year.
Average pay of disclosed executives at Enochian Biosciences
Mark Dybul, Chief Executive Officer, received $11M in total, which increased by 2,400% compared to 2021. 91% of Dybul's compensation, or $9.8M, was in option awards. Dybul also received $100K in bonus and $850K in salary.
Luisa Puche, Chief Financial Officer, received a compensation package of $789K, which increased by 187% compared to previous year. 48% of the compensation package, or $376K, was in option awards.
Enochian Biosciences' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on May 16, 2023.